Analogy of human immunodeficiency virus to hepatitis C virus: the human immunodeficiency model

Friedman, 1999, The evaluation of fibrosis and hepatitis C, Am J Med, 107, 27S, 10.1016/S0002-9343(99)00377-0 Haynes, 1997, Immune response to human immunodeficiency virus infection, 89 Mellors, 1997, Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection, Ann Intern Med, 126, 946, 10.7326/0003-4819-126-12-199706150-00003 Richman, 1994, Nevirapine resis-tance mutations of human imunodeficiency virus type 1 selected during therapy, J Virol, 68, 1660, 10.1128/JVI.68.3.1660-1666.1994 Palella, 1998, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators, N Engl J Med, 338, 853, 10.1056/NEJM199803263381301 Bacon, 1999, Available options for treatment of interferon nonresponders, Am J Med, 107, 67S, 10.1016/S0002-9343(99)00386-1 Jacobson, 1999, Management of interferon relapsers, Am J Med, 107, 62S, 10.1016/S0002-9343(99)00385-X Layden, 1999, Principles of interferon induction therapy, Am J Med, 107, 71S, 10.1016/S0002-9343(99)00387-3 Di Bisceglie, 1999, Hepatitis C—virology and future antiviral targets, Am J Med, 107, 45S, 10.1016/S0002-9343(99)00381-2 Perelson, 1999, Viral kinetics and mathematical models, Am J Med, 107, 49S, 10.1016/S0002-9343(99)00382-4 Dieterich, 1999, Hepatitis C virus and human immunodeficiency virus, Am J Med, 107, 79S, 10.1016/S0002-9343(99)00390-3